髋膝骨关节炎随机试验样本量计算与报告方法学现状:系统评价方案
本方案拟系统评价2016年发表的髋膝骨关节炎随机对照试验中样本量确定的方法与报告质量。将检索Medline、Cochrane library、CINAHL、EMBASE、PsycINFO、PEDro和AMED等数据库,由两名评价者独立筛选与提取数据,汇总样本量计算关键组成部分的报告比例并检验其可重复性。
要点
- 拟系统评价2016年发表的髋膝骨关节炎随机对照试验的样本量确定方法与报告。
- 将提取研究特征、主要结局、样本量及计算依据与参数,汇总关键组成部分报告比例。
- 将检验样本量计算的可重复性,并总结当前实践与报告完整性证据。
核心结论
- 本系统评价将总结髋膝骨关节炎试验中样本量计算的当前实践,并提供样本量计算报告完整性、所选样本量可重复性及计算取值依据的证据。
研究设计与样本
- 系统评价方案,检索Medline、Cochrane library、CINAHL、EMBASE、PsycINFO、PEDro和AMED等电子数据库,纳入2016年发表的髋膝骨关节炎随机对照试验。
- 由两名评价者独立筛选文献与提取数据。
主要发现
- 将提取研究特征(设计、人群、干预与对照治疗)、主要结局、所选样本量及依据、用于计算样本量的参数(包括对照组治疗效应、主要结局变异程度、失访率)。
- 将使用适当的汇总统计量(如n和%、中位数和四分位距)汇总数据,并呈现报告样本量计算各关键组成部分的研究比例。
- 将检验样本量计算的可重复性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A key aspect of the design of randomised controlled trials (RCTs) is determining the sample size. It is important that the trial sample size is appropriately calculated. The required sample size will differ by clinical area, for instance, due to the prevalence of the condition and the choice of primary outcome. Additionally, it will depend upon the choice of target difference assumed in the calculation. Focussing upon the hip and knee osteoarthritis population, this study aims to systematically review how the trial size was determined for trials of osteoarthritis, on what basis, and how well these aspects are reported. METHODS: Several electronic databases (Medline, Cochrane library, CINAHL, EMBASE, PsycINFO, PEDro and AMED) will be searched to identify articles on RCTs of hip and knee osteoarthritis published in 2016. Articles will be screened for eligibility and data extracted independently by two reviewers. Data will be extracted on study characteristics (design, population, intervention and control treatments), primary outcome, chosen sample size and justification, parameters used to calculate the sample size (including treatment effect in control arm, level of variability in primary outcome, loss to follow-up rates). Data will be summarised across the studies using appropriate summary statistics (e.g. n and %, median and interquartile range). The proportion of studies which report each key component of the sample size calculation will be presented. The reproducibility of the sample size calculation will be tested. DISCUSSION: The findings of this systematic review will summarise the current practice for sample size calculation in trials of hip and knee osteoarthritis. It will also provide evidence on the completeness of the reporting of the sample size calculation, reproducibility of the chosen sample size and the basis for the values used in the calculation. TRIAL REGISTRATION: As this review was not eligible to be registered on PROSPERO, the summary information was uploaded to Figshare to make it publicly accessible in order to avoid unnecessary duplication amongst other benefits ( https://doi.org/10.6084/m9.figshare.5009027.v1) ; Registered January 17, 2017.
引用
- Copsey B, Dutton S, Fitzpatrick R, et al. Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a protocol for a systematic review. Trials. 2017. PMID: 29017518. doi:10.1186/s13063-017-2209-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。